Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans. Several
risk factors promote AF, among which diabetes mellitus has emerged as one of the most …

Background Traditional risk factors are insufficient to explain all cases of coronary artery
disease (CAD) in patients with diabetes mellitus (DM). Advanced glycation end-products …

Obesity and diabetes are leading causes of cardiovascular morbidity and mortality. Although
extensive strides have been made in the treatments for non-diabetic atherosclerosis and its …

Age-related, non-communicable chronic inflammatory diseases represent the major 21st
century health problem. Especially in Western countries, the prevalence of non …

Chronic obstructive pulmonary disease (COPD) is a disease of the airways and lungs due to
an enhanced inflammatory response, commonly caused by cigarette smoking. Patients with …

Aims Diabetes mellitus (DM) and atrial fibrillation (AF) share pathophysiological links, as
supported by the high prevalence of AF within DM patients. Catheter ablation of AF (AFCA) …

Cardiovascular disease (CVD) is the leading cause of death in the world. In 2019, 550
million people were suffering from CVD and 18 million of them died as a result. Most of them …

Atrial fibrillation (AF) is an important cause of stroke and risk factor for heart failure and
death. Current pharmacologic treatments for AF have limited efficacy, and treatments that …

Background Apart from several established clinical risk factors for atrial fibrillation (AF), a
number of biomarkers have also been identified as potential risk factors for AF. None of …

Glycation and glycosylation are non-enzymatic and enzymatic reactions, respectively, of
glucose, glucose metabolites, and other reducing sugars with different substrates, such as …